High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva
- 1 January 1998
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 705 (1), 119-126
- https://doi.org/10.1016/s0378-4347(97)00500-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjectsAntimicrobial Agents and Chemotherapy, 1997
- Ordered accumulation of mutations in HIV protease confers resistance to ritonavirNature Medicine, 1996
- A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 InfectionNew England Journal of Medicine, 1995
- A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 ProteaseNew England Journal of Medicine, 1995
- Quantification of the anti‐HIV drug saquinavir by high‐speed on‐line high‐performance liquid chromatography/tandem mass spectrometryJournal of Mass Spectrometry, 1995
- ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.Proceedings of the National Academy of Sciences, 1995
- Calibration and validation of linearity in chromatographic biopharmaceutical analysisJournal of Pharmaceutical and Biomedical Analysis, 1991